russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2025-6405NIAIKYrussjcardiol-6405Research ArticleОБЩЕСТВЕННОЕ ЗДОРОВЬЕ И ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯОрганизация медицинской помощи при остром коронарном синдроме в рамках федерального проекта «Борьба с сердечно-сосудистыми заболеваниями»: результаты и перспективыManagement of health care for acute coronary syndrome within the federal project "Control of Cardiovascular Diseases": results and prospectshttps://orcid.org/0000-0003-1358-110XКамкинЕ. Г.KamkinE. G.

Камкин Евгений Геннадьевич — к.м.н., зам. Министра здравоохранения Российской Федерации

Москва

Moscow

info@minzdrav.gov.ruhttps://orcid.org/0000-0001-5222-1620КаракулинаЕ. В.KarakulinaE. V.

Каракулина Екатерина Валерьевна — к.м.н., директор департамента организации медицинской помощи и санаторно-­курортного дела

Москва

Moscow

info@minzdrav.gov.ruhttps://orcid.org/0009-0007-4819-4405ГульшинаВ. А.GulshinaV. A.

Гульшина Валерия Александровна — к.б.н., зам. директора департамента организации медицинской помощи и санаторно-­курортного дела

Москва

Moscow

info@minzdrav.gov.ruhttps://orcid.org/0009-0005-0869-2456МоскалёвА. А.MoskalevA. A.

Москалев Андрей Александрович — начальник отдела реализации региональных программ организации медицинской помощи и санаторно-­курортного дела

Москва

Moscow

info@minzdrav.gov.ruhttps://orcid.org/0009-0006-9300-7210АнисимоваН. С.AnisimovaN. S.

Анисимова Наталья Сергеевна — к.м.н., зам. начальника отдела реализации региональных программ организации медицинской помощи и санаторно-­курортного дела

Москва

Moscow

info@minzdrav.gov.ruhttps://orcid.org/0009-0007-8509-0488МазыгулаЕ. П.MazygulaE. P.

Мазыгула Елена Петровна — к.м.н., руководитель Координационного центра по реализации федерального проекта "Борьба с сердечно-­сосудистыми заболеваниями"

Москва

Moscow

mazygula@yandex.ruИващенкоР. М.IvaschenkoR. M.

Иващенко Регина Маратовна — зам. руководителя Координационного центра по реализации федерального проекта "Борьба с сердечно-­сосудистыми заболеваниями"

Москва

Moscow

reginab_md@mail.ruhttps://orcid.org/0009-0005-0064-0192ЧекулаевА. С.ChekulaevA. S.

Чекулаев Александр Сергеевич — зав. отделом методической поддержки и координации мероприятий федерального проекта "Борьба с сердечно-сосудистыми заболеваниями"

Москва

Moscow

a.chekulaev@internet.ruhttps://orcid.org/0000-0001-6533-5950ЗвартауН. Э.ZvartauN. E.

Звартау Надежда Эдвиновна — к.м.н., зам. генерального директора по работе с регионами, доцент кафедры факультетской терапии с клиникой Института медицинского образования

Санкт-Петербург

St. Petersburg

zvartau_ne@almazovcentre.ruhttps://orcid.org/0000-0001-5656-3978ЯковлевА. Н.YakovlevA. N.

Яковлев Алексей Николаевич — к.м.н., начальник службы по развитию регионального здравоохранения Управления по реализации федеральных проектов, зав. научно-­исследовательской лабораторией острого коронарного синдрома, доцент кафедры анестезиологии и реаниматологии лечебного факультета Института медицинского образования

Санкт-Петербург

St. Petersburg

yakovlev_an@almazovcentre.ruhttps://orcid.org/0000-0001-7652-2962ВиллевальдеС. В.VillevaldeS. V.

Виллевальде Светлана Вадимовна — д.м.н., профессор, начальник службы анализа и перспективного планирования Управления по реализации федеральных проектов, зав. кафедрой кардиологии факультета послевузовского и дополнительного образования Института медицинского образования

Санкт-Петербург

St. Petersburg

villevalde_sv@almazovcentre.ruhttps://orcid.org/0000-0002-5130-5192МедведеваЕ. А.MedvedevaE. A.

Медведева Елена Александровна — к.м.н., зав. отделом стратегического развития кардиологической службы в регионах Управления по реализации федеральных проектов

Санкт-Петербург

St. Petersburg

medvedeva_e_a@almazovcentre.ruhttps://orcid.org/0000-0001-7278-6581НедбаеваД. Н.NedbaevaD. N.

Недбаева Дарья Николаевна — специалист отдела мониторинга и анализа показателей регионального здравоохранения Службы по развитию регионального здравоохранения Управления по реализации федеральных проектов

Санкт-Петербург

St. Petersburg

nedbaeva_dn@almazovcentre.ruhttps://orcid.org/0000-0002-9836-7841ФедоренкоА. А.FedorenkoA. A.

Федоренко Алексей Александрович — зам. начальника службы по развитию регионального здравоохранения Управления по реализации федеральных проектов

Санкт-Петербург

St. Petersburg

fedorenko_aa@almazovcentre.ruhttps://orcid.org/0000-0003-2428-2375ДаутовД. Р.DautovD. R.

Даутов Дмитрий Рафагатьевич — врач-кардиолог отдела информационного обеспечения и телемедицины Управления по реализации федеральных проектов

Санкт-Петербург

St. Petersburg

ddautov97@yandex.ruhttps://orcid.org/0000-0003-2929-0980ШляхтоЕ. В.ShlyakhtoE. V.

Шляхто Евгений Владимирович — д.м.н., профессор, академик РАН, генеральный директор, главный внештатный специалист кардиолог Минздрава России Северо-­Западного, Северо-Кавказского, Приволжского и Южного федеральных округов, Херсонской и Запорожской областей

Санкт-Петербург

St. Petersburg

fmrc@almazovcentre.ruМинистерство здравоохранения Российской ФедерацииРоссияMinistry of Health of the Russian FederationRussian FederationФГБУ Центральный научно-исследовательский институт организации и информатизации здравоохранения Минздрава РоссииРоссияCentral Research Institute for Healthcare Organization and InformatizationRussian FederationФГБУ Национальный медицинский исследовательский центр им. В. А. Алмазова Минздрава РоссииРоссияAlmazov National Medical Research CenterRussian Federation20251010202530964056405Copyright © Камкин Е.Г., Каракулина Е.В., Гульшина В.А., Москалёв А.А., Анисимова Н.С., Мазыгула Е.П., Иващенко Р.М., Чекулаев А.С., Звартау Н.Э., Яковлев А.Н., Виллевальде С.В., Медведева Е.А., Недбаева Д.Н., Федоренко А.А., Даутов Д.Р., Шляхто Е.В., 20252025Камкин Е.Г., Каракулина Е.В., Гульшина В.А., Москалёв А.А., Анисимова Н.С., Мазыгула Е.П., Иващенко Р.М., Чекулаев А.С., Звартау Н.Э., Яковлев А.Н., Виллевальде С.В., Медведева Е.А., Недбаева Д.Н., Федоренко А.А., Даутов Д.Р., Шляхто Е.В.Kamkin E.G., Karakulina E.V., Gulshina V.A., Moskalev A.A., Anisimova N.S., Mazygula E.P., Ivaschenko R.M., Chekulaev A.S., Zvartau N.E., Yakovlev A.N., Villevalde S.V., Medvedeva E.A., Nedbaeva D.N., Fedorenko A.A., Dautov D.R., Shlyakhto E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/6405

Инфаркт миокарда (ИМ) продолжает сохранять статус одного из ключевых жизнеугрожающих сердечно-сосудистых заболеваний с высоким бременем заболеваемости и смертности, включая население трудоспособного возраста. В рамках федерального проекта "Борьба с сердечно-сосудистыми заболеваниями" в Российской Федерации в 2019-2024гг была проведена масштабная модернизация системы оказания медицинской помощи при остром коронарном синдроме и ИМ: расширена сеть региональных сосудистых центров, оптимизирована маршрутизация пациентов, что позволило увеличить охват чрескожным коронарным вмешательством при ИМ с подъемом сегмента ST с 56% до 77%, а при ИМбпST — с 21% до 48%, и достичь снижения смертности от ИМ на 100 тыс. населения на 19,6%, а больничной летальности от ИМ — на 32%. Однако сохраняются межрегиональные различия, в связи с чем необходима дальнейшая работа над повышением доступности и своевременности реперфузионной терапии. В рамках федерального проекта "Борьба с сердечнососудистыми заболеваниями" Национального проекта "Продолжительная и активная жизнь" будет происходить мониторинг целевого показателя охвата реперфузионной терапией больных ИМ, госпитализированных в первые сутки от начала заболевания, уровень которого должен достичь 95% к 2030г. Реализация дополнительных мероприятий позволит сократить дифференциацию показателей между регионами, снизить смертность от болезней системы кровообращения и достичь национальных целей по увеличению продолжительности жизни.

Myocardial infarction (MI) continues to retain the status of one of the key lifethreatening cardiovascular diseases with a high morbidity and mortality, including the working-age population. As part of the federal project "Control of Cardiovascular Diseases" in the Russian Federation in 2019-2024, a large-scale modernization of healthcare system for acute coronary syndrome and MI was carried out. The network of regional vascular centers was expanded and patient routing was optimized, which made it possible to increase the coverage of percutaneous coronary intervention for ST-segment elevation MI from 56% to 77%, and for NSTEMI — from 21% to 48%, and to achieve a decrease in mortality from MI per 100 thousand people by 19,6%, and inhospital mortality from MI — by 32%. However, interregional differences remain, and therefore further work is needed to improve the availability and timing of reperfusion therapy. Within the federal project "Control of Cardiovascular Diseases" of the National Project "Long and Active Life", the target indicator of reperfusion therapy coverage of patients with MI hospitalized within the first 24 hours from the disease onset will be monitored. Its level should reach 95% by 2030. Implementation of additional measures will reduce the differentiation of indicators between regions, reduce cardiovascular mortality and achieve national goals to increase life expectancy.

острый коронарный синдроминфаркт миокардареперфузионная терапиятромболитическая терапиячрескожное коронарное вмешательствореваскуляризациямаршрутизациябольничная летальностьacute coronary syndromemyocardial infarctionreperfusion therapythrombolytic therapypercutaneous coronary interventionrevascularizationroutinghospital mortalityReferencesАверков О.В., Арутюнян Г.К., Дупляков Д.В. и др. Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2024. Российский кардиологический журнал. 2025;30(3): 6306. doi:10.15829/1560-4071-2025-6306. EDN: IVJCUK.Averkov OV, Harutyunyan GK, Duplyakov DV, et al. 2024 Clinical practice guidelines for Acute myocardial infarction with ST segment elevation electrocardiogram. Russian Journal of Cardiology. 2025;30(3):6306. (In Russ.) doi:10.15829/1560-4071-2025-6306. EDN: IVJCUK.Аверков О.В., Арутюнян Г.К., Дупляков Д.В. и др. Острый коронарный синдром без подъема сегмента ST электрокардиограммы. Клинические рекомендации 2024. Российский кардиологический журнал. 2025;30(5): 6319. doi:10.15829/1560-4071-2025-6319. EDN: CXJUIB.Averkov OV, Harutyunyan GK, Duplyakov DV, et al. 2024 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation electrocardiogram. Russian Journal of Cardiology. 2025;30(5):6319. (In Russ.) doi:10.15829/1560-4071-2025-6319. EDN: CXJUIB.Williams C, Fordyce CB, Cairns JA, et al. Temporal Trends in Reperfusion Delivery and Clinical Outcomes Following Implementation of a Regional STEMI Protocol: A 12-Year Perspective. CJC Open. 2022;5(3):181-90. doi:10.1016/j.cjco.2022.11.015.Williams C, Fordyce CB, Cairns JA, et al. Temporal Trends in Reperfusion Delivery and Clinical Outcomes Following Implementation of a Regional STEMI Protocol: A 12-Year Perspective. CJC Open. 2022;5(3):181-90. doi:10.1016/j.cjco.2022.11.015.Jortveit J, Pripp AH, Halvorsen S. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-¬invasive strategy in ST-segment elevation myocardial infarction in Norway. Eur Heart J Cardiovasc Pharmacother. 2022;8(5):442-51. doi:10.1093/ehjcvp/pvab041.Jortveit J, Pripp AH, Halvorsen S. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-¬invasive strategy in ST-segment elevation myocardial infarction in Norway. Eur Heart J Cardiovasc Pharmacother. 2022;8(5):442-51. doi:10.1093/ehjcvp/pvab041.Eastwood K, Howell S, Nehme Z, et al. Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome. Open Heart. 2021;8:e001792. doi:10.1136/openhrt2021-001792.Eastwood K, Howell S, Nehme Z, et al. Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome. Open Heart. 2021;8:e001792. doi:10.1136/openhrt2021-001792.Thygesen K, Alpert JS, Jaffe AS, et al.; ЕОК Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237-69. doi:10.1161/CIR.0000000000000617.Thygesen K, Alpert JS, Jaffe AS, et al.; ЕОК Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237-69. doi:10.1161/CIR.0000000000000617.Diercks DB, Peacock WF, Hiestand BC, et al. Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-¬STsegment elevation acute coronary syndromes (from the CRUSADE Initiative). Am J Cardiol. 2006;97:437-42. doi:10.1016/j.amjcard.2005.09.073.Diercks DB, Peacock WF, Hiestand BC, et al. Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-¬STsegment elevation acute coronary syndromes (from the CRUSADE Initiative). Am J Cardiol. 2006;97:437-42. doi:10.1016/j.amjcard.2005.09.073.Schmitt C, Lehmann G, Schmieder S, et al. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel: limitations of ST-segment elevation in standard and extended ECG leads. Chest. 2001;120:1540-6. doi:10.1378/chest.120.5.1540.Schmitt C, Lehmann G, Schmieder S, et al. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel: limitations of ST-segment elevation in standard and extended ECG leads. Chest. 2001;120:1540-6. doi:10.1378/chest.120.5.1540.Fesmire FM, Percy RF, Bardoner JB, et al. Usefulness of automated serial 12 lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med. 1998;31:3-11. doi:10.1016/S0196-0644(98)70274-4.Fesmire FM, Percy RF, Bardoner JB, et al. Usefulness of automated serial 12 lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med. 1998;31:3-11. doi:10.1016/S0196-0644(98)70274-4.Rouan GW, Lee TH, Cook EF, et al. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). Am J Cardiol. 1989;64:1087-92. doi:10.1016/00029149(89)90857-6.Rouan GW, Lee TH, Cook EF, et al. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). Am J Cardiol. 1989;64:1087-92. doi:10.1016/00029149(89)90857-6.McCarthy BD, Wong JB, Selker HP. Detecting acute cardiac ischemia in the emergency department. J Gen Intern Med. 1990;5:365-73. doi:10.1007/BF02600409.McCarthy BD, Wong JB, Selker HP. Detecting acute cardiac ischemia in the emergency department. J Gen Intern Med. 1990;5:365-73. doi:10.1007/BF02600409.Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707-13. doi:10.1001/jama.281.8.707.Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707-13. doi:10.1001/jama.281.8.707.Дроздов Д.В., Макаров Л.М., Иртюга О.Б. и др. Регистрация электрокардиограммы покоя в 12 общепринятых отведениях взрослым и детям 2023. Методические рекомендации. Российский кардиологический журнал. 2023;28(10):5631. doi:10.15829/1560-4071-2023-5631.Drozdov DV, Makarov LM, Barkan VS, et al. Resting 12 lead electrocardiography for adults and children. 2023 Guidelines. Russian Journal of Cardiology. 2023;28(10):5631. (In Russ.) doi:10.15829/1560-4071-2023-5631.Bainey KR, Armstrong PW, Zheng Y, et al. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry. Circ Cardiovasc Interv. 2019;12(10):e008059. doi:10.1161/CIRCINTERVENTIONS.119.008059.Bainey KR, Armstrong PW, Zheng Y, et al. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry. Circ Cardiovasc Interv. 2019;12(10):e008059. doi:10.1161/CIRCINTERVENTIONS.119.008059.Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771-5. doi:10.1016/s0140-6736(96)02514-7.Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771-5. doi:10.1016/s0140-6736(96)02514-7.Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779-88. doi:10.1093/eurheartj/ehi810.Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779-88. doi:10.1093/eurheartj/ehi810.Byrne RA, Rossello X, Coughlan JJ, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. doi:10.1093/eurheartj/ehad191.Byrne RA, Rossello X, Coughlan JJ, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. doi:10.1093/eurheartj/ehad191.O’Gara PT, Kushner FG, Ascheim DD, et al.; American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362-425. doi:10.1161/CIR.0b013e3182742cf6.O’Gara PT, Kushner FG, Ascheim DD, et al.; American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362-425. doi:10.1161/CIR.0b013e3182742cf6.Steg PG, James SK, Atar D, et al. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC); ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-619. doi:10.1093/eurheartj/ehs215.Steg PG, James SK, Atar D, et al. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC); ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-619. doi:10.1093/eurheartj/ehs215.Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. J Am Med Assoc. 2000;283:2686-92. doi:10.1001/jama.283.20.2686.Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. J Am Med Assoc. 2000;283:2686-92. doi:10.1001/jama.283.20.2686.McCaul M, Lourens A, Kredo T. Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction Cochrane Database Syst Rev. 2014:(9):CD010191. doi:10.1002/14651858.CD010191.pub2.McCaul M, Lourens A, Kredo T. Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction Cochrane Database Syst Rev. 2014:(9):CD010191. doi:10.1002/14651858.CD010191.pub2.Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5 year follow-up. Eur Heart J. 2009;30(13):1598-606. doi:10.1093/eurheartj/ehp156.Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5 year follow-up. Eur Heart J. 2009;30(13):1598-606. doi:10.1093/eurheartj/ehp156.Armstrong PW, Gershlick AH, Goldstein P, et al.; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368(15):1379-87. doi:10.1056/NEJMoa1301092.Armstrong PW, Gershlick AH, Goldstein P, et al.; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368(15):1379-87. doi:10.1056/NEJMoa1301092.Ellis SG, da Silva ER, Heyndrickx G, et al.; RЕSCUE Investigators. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 1994;90(5):2280-4. doi:10.1161/01.cir.90.5.2280.Ellis SG, da Silva ER, Heyndrickx G, et al.; RЕSCUE Investigators. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 1994;90(5):2280-4. doi:10.1161/01.cir.90.5.2280.Sutton AGC, Campbell PG, Graham R, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol. 2004;44:287-96. doi:10.1016/j.jacc.2003.12.059.Sutton AGC, Campbell PG, Graham R, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol. 2004;44:287-96. doi:10.1016/j.jacc.2003.12.059.Wijeysundera H, Vijayaraghavan R, Nallamothu B, et al. Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta--Analysis of Randomized Trials. JACC. 2007;49(4):422-30. doi:10.1016/j.jacc.2006.09.033.Wijeysundera H, Vijayaraghavan R, Nallamothu B, et al. Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta--Analysis of Randomized Trials. JACC. 2007;49(4):422-30. doi:10.1016/j.jacc.2006.09.033.Collet JP, Montalesot G, Le May M, et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J Am Coll Cardiol. 2006;48:1326-35. doi:10.1016/j.jacc.2006.03.064.Collet JP, Montalesot G, Le May M, et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J Am Coll Cardiol. 2006;48:1326-35. doi:10.1016/j.jacc.2006.03.064.Appleton DL, Abbate A, Biondi-¬Zoccai GGL. Late percutaneous coronary intervention for the totally occluded infarct-¬related artery: a meta-analysis of the effects on cardiac function and remodeling. Catheter Cardiovasc Interv. 2008;71:772-81. doi:10.1002/ccd.21468.Appleton DL, Abbate A, Biondi-¬Zoccai GGL. Late percutaneous coronary intervention for the totally occluded infarct-¬related artery: a meta-analysis of the effects on cardiac function and remodeling. Catheter Cardiovasc Interv. 2008;71:772-81. doi:10.1002/ccd.21468.Borgia F, Goodman SG, Halvorsen S, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J. 2010;31(17):2156-69. doi:10.1093/eurheartj/ehq204.Borgia F, Goodman SG, Halvorsen S, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J. 2010;31(17):2156-69. doi:10.1093/eurheartj/ehq204.D’Souza SP, Mamas MA, Fraser DG, et al. Routine early coronary angioplasty versus ischaemia-¬guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. Eur Heart J. 2011;32(8):972-82. doi:10.1093/eurheartj/ehq398.D’Souza SP, Mamas MA, Fraser DG, et al. Routine early coronary angioplasty versus ischaemia-¬guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. Eur Heart J. 2011;32(8):972-82. doi:10.1093/eurheartj/ehq398.Hochman JS, Lamas GA, Buller CE, et al.; Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006; 355(23):2395-407. doi:10.1056/NEJMoa066139.Hochman JS, Lamas GA, Buller CE, et al.; Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006; 355(23):2395-407. doi:10.1056/NEJMoa066139.Schömig A, Mehilli J, Antoniucci D, et al. Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial. JAMA. 2005;293(23):2865-72. doi:10.1001/jama.293.23.2865.Schömig A, Mehilli J, Antoniucci D, et al. Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial. JAMA. 2005;293(23):2865-72. doi:10.1001/jama.293.23.2865.Nadrepepa G, Kastrati A, Mehilli J, et al. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. JAMA. 2009;301(5):487-8. doi:10.1001/jama.2009.32.Nadrepepa G, Kastrati A, Mehilli J, et al. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. JAMA. 2009;301(5):487-8. doi:10.1001/jama.2009.32.Bouisset F, Gerbaud E, Bataille V, et al. Percutaneous myocardial revascularization in latepresenting patients with STEMI. J Am Coll Cardiol. 2021;78:1291-305. doi:10.1016/j.jacc.2021.07.039.Bouisset F, Gerbaud E, Bataille V, et al. Percutaneous myocardial revascularization in latepresenting patients with STEMI. J Am Coll Cardiol. 2021;78:1291-305. doi:10.1016/j.jacc.2021.07.039.Busk M, Kaltoft A, Nielsen SS, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J. 2009;30:1322-30. doi:10.1093/eurheartj/ehp113.Busk M, Kaltoft A, Nielsen SS, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J. 2009;30:1322-30. doi:10.1093/eurheartj/ehp113.Ioannidis JP, Katritsis DG. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. Am Heart J. 2007;154(6):1065-71. doi:10.1016/j.ahj.2007.07.049.Ioannidis JP, Katritsis DG. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. Am Heart J. 2007;154(6):1065-71. doi:10.1016/j.ahj.2007.07.049.Menon V, Pearte CA, Buller CE, et al. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. Eur Heart J. 2009;30(2):183-91. doi:10.1093/eurheartj/ehn486.Menon V, Pearte CA, Buller CE, et al. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. Eur Heart J. 2009;30(2):183-91. doi:10.1093/eurheartj/ehn486.Wald DS, Morris JK, Wald NJ, et al. & PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. The New England journal of medicine. 2013;369(12):1115-23. doi:10.1056/NEJMoa1305520.Wald DS, Morris JK, Wald NJ, et al. & PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. The New England journal of medicine. 2013;369(12):1115-23. doi:10.1056/NEJMoa1305520.Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI 3 — PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665-71. doi:10.1016/s0140-6736(15)60648-1.Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI 3 — PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665-71. doi:10.1016/s0140-6736(15)60648-1.Smits PC, Abdel-¬Wahab M, Neumann FJ, et al. Fractional flow reserve-¬guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234-44. doi:10.1056/NEJMoa1701067.Smits PC, Abdel-¬Wahab M, Neumann FJ, et al. Fractional flow reserve-¬guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234-44. doi:10.1056/NEJMoa1701067.Mehta SR, Wang J, Wood DA, et al.; COMPLETE Trial Investigators. Complete Revascularization vs Culprit Lesion-¬Only Percutaneous Coronary Intervention for Angina--Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. JAMA cardiology. 2022;7(11):1091-9. doi:10.1001/jamacardio.2022.3032.Mehta SR, Wang J, Wood DA, et al.; COMPLETE Trial Investigators. Complete Revascularization vs Culprit Lesion-¬Only Percutaneous Coronary Intervention for Angina--Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. JAMA cardiology. 2022;7(11):1091-9. doi:10.1001/jamacardio.2022.3032.Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963-72. doi:10.1016/j.jacc.2014.12.038.Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963-72. doi:10.1016/j.jacc.2014.12.038.Chin CT, L’Allier P, Neumann FJ, et al. The Compare-¬Acute trial of fractional flow reserve--guided multivessel angioplasty in myocardial infarction. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017;13(5):e613 e616. doi:10.4244/EIJV13I5A96.Chin CT, L’Allier P, Neumann FJ, et al. The Compare-¬Acute trial of fractional flow reserve--guided multivessel angioplasty in myocardial infarction. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017;13(5):e613 e616. doi:10.4244/EIJV13I5A96.Diletti R, den Dekker WK, Bennett J; BIOVASC Investigators. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023;401(10383):1172-82. doi:10.1016/S0140-6736(23)00351-3.Diletti R, den Dekker WK, Bennett J; BIOVASC Investigators. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023;401(10383):1172-82. doi:10.1016/S0140-6736(23)00351-3.Biscaglia S, Guiducci V, Escaned J, et al.; FIRE Trial Investigators. Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction. N Engl J Med. 2023;389(10):88998. doi:10.1056/NEJMoa2300468.Biscaglia S, Guiducci V, Escaned J, et al.; FIRE Trial Investigators. Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction. N Engl J Med. 2023;389(10):88998. doi:10.1056/NEJMoa2300468.Reichlin T, Twerenbold R, Reiter M, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med. 2012;125:1205-13. doi:10.1016/j.amjmed.2012.07.015.Reichlin T, Twerenbold R, Reiter M, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med. 2012;125:1205-13. doi:10.1016/j.amjmed.2012.07.015.Сhapman AR, Lee KK, McAllister DA, et al. Association of High-¬Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. 2017;318:1913-24. doi:10.1001/jama.2017.17488.Сhapman AR, Lee KK, McAllister DA, et al. Association of High-¬Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. 2017;318:1913-24. doi:10.1001/jama.2017.17488.Mueller C, Giannitsis E, Mockel M, et al., Biomarker Study Group of the ESC ACCA. Rapid rule out of acute myocardial infarction: novel biomarker-¬based strategies. Eur Heart J Acute Cardiovasc Care. 2017;6:218-22. doi:10.1177/2048872616653229.Mueller C, Giannitsis E, Mockel M, et al., Biomarker Study Group of the ESC ACCA. Rapid rule out of acute myocardial infarction: novel biomarker-¬based strategies. Eur Heart J Acute Cardiovasc Care. 2017;6:218-22. doi:10.1177/2048872616653229.Pickering JW, Than MP, Cullen L, et al. Rapid Rule-out of Acute Myocardial Infarction With a Single HighSensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. Ann Intern Med. 2017;166:715-3724. doi:10.7326/M16-2562.Pickering JW, Than MP, Cullen L, et al. Rapid Rule-out of Acute Myocardial Infarction With a Single HighSensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. Ann Intern Med. 2017;166:715-3724. doi:10.7326/M16-2562.Miller-¬Hodges E, Anand A, Shah ASV, et al. High-¬Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome. Circulation. 2018;137:425-35. doi:10.1161/CIRCULATIONAHA.117.030320.Miller-¬Hodges E, Anand A, Shah ASV, et al. High-¬Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome. Circulation. 2018;137:425-35. doi:10.1161/CIRCULATIONAHA.117.030320.Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal. 2016;37(42):3232-45. doi:10.1093/eurheartj/ehw334.Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal. 2016;37(42):3232-45. doi:10.1093/eurheartj/ehw334.Abu-¬Assi E, López-¬López A, González-¬Salvado V, et al. The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization. Revista Espanola de Cardiologia. 2016;69(1):11-8. doi:10.1016/j.rec.2015.06.015.Abu-¬Assi E, López-¬López A, González-¬Salvado V, et al. The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization. Revista Espanola de Cardiologia. 2016;69(1):11-8. doi:10.1016/j.rec.2015.06.015.Bouisset F, Ruidavets J-B, Dallongeville J, et al. Comparison of Short- and Long-¬Term Prognosis between ST-Elevation and Non-¬ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 2021;10(2):180. doi:10.3390/jcm10020180.Bouisset F, Ruidavets J-B, Dallongeville J, et al. Comparison of Short- and Long-¬Term Prognosis between ST-Elevation and Non-¬ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 2021;10(2):180. doi:10.3390/jcm10020180.

The authors declare that there are no conflicts of interest present.